36. Harnessing the innate immune system to combat disease, RJ Tesi, CEO and CMO, INmune Bio
Dr. Raymond J. Tesi has been President, Chief Executive Officer and acting Chief Medical Officer since the formation of INmune Bio in September 2015. From November 2011 to May 2015, Dr. Tesi was CEO, ...
28 Okt 202024min
35. Continuous manufacturing in drug development, Matthew Bio, CEO, Snapdragon Chemistry
Dr. Matthew Bio is President & CEO at Snapdragon Chemistry. Matthew began his career in chemistry more than 20 years ago developing continuous processes for the manufacture and purification of acryla...
21 Okt 202027min
34. Automation and Regenerative Manufacturing, Alexander Titus, Chief Strategy Officer, ARMI
Alexander Titus is the Founder of Bioeconomy.XYZ and the Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI), where his career focuses on the intersection of techn...
14 Okt 202030min
33. RNA modification gene therapy for rare disorders, Jim Burns, CEO, Kathie Bishop, CSO, Locanabio
James Burns, PhD, Chief Executive Officer, Locanabio James (Jim) Burns, Ph.D., joined Locanabio in December 2019 as CEO and Board member. Prior to joining Locanabio, Dr. Burns served as the CEO of Ca...
7 Okt 202027min
32. Vaccine origins to combat COVID-19, Seth Lederman, Co-Founder/CEO, Tonix Pharmaceuticals
Seth Lederman is a physician, scientist and founder and executive officer of innovative biopharmaceuticals companies. Prior to founding Tonix, among the companies Dr. Lederman founded was Targent Phar...
30 Sep 202018min
31. Drug discovery for neurodegenerative diseases, Victor Hanson-Smith, Comp. Bio., Verge Genomics
Victor Hanson-Smith is the Head of Computational Biology at Verge Genomics and is one of the world's leaders in mathematical modeling of eukaryotic genome evolution and function. He has co-authored 13...
23 Sep 202021min
30. Genetics and synthetic biology for trailblazing drug discovery, Maria Soloveychik, CEO, SyntheX
Dr. Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company focused on accelerating drug discovery using synthetic biology. The company’s core technologies, ToRPPIDO and ToRNeDO...
16 Sep 202017min
29. Breakthrough imaging device for noninvasive cancer detection: Bob Proulx, CEO Imagion Biosystems
Bob has been President of Imagion Biosystems since February 2015 and has led the company through the recent restructuring and recapitalization efforts. Previous employment experience includes Pres/GM ...
9 Sep 202025min
